BACKGROUND: While perinatal depression is one of the most common complications of pregnancy, there is an insufficient understanding of the mechanistic underpinnings of disease. While an association between peripheral inflammatory cytokines and major depressive disorder has been demonstrated, cytokines cannot freely cross the blood-brain barrier, and thus, they give little insight into alternations in brain function. Because the brain is in direct communication with the cerebrospinal fluid, assessment of inflammation in the cerebrospinal fluid may be more directly related to the biologic markers of affective change. OBJECTIVE: Our objectives were to examine the association between perinatal depression and inflammatory cytokines in plasma, the association between perinatal depression and inflammatory cytokines in cerebrospinal fluid, and the correlations between plasma and cerebrospinal fluid inflammatory cytokines. STUDY DESIGN: This was a prospective, observational study of women with a singleton gestation at term undergoing a scheduled cesarean delivery. Women were screened for depression and those with depressive symptomatology preferentially enrolled. The Mini-International Neuropsychiatric Interview was administered to confirm the clinical diagnosis of depression. Maternal plasma and cerebrospinal fluid were collected preoperatively and cytokines measured via flow cytometry. Bivariable and multivariable analyses were used to determine the
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epression is becoming increasingly recognized as a disorder of immune hyperactivation. 1e8 Patients with major depressive disorder have increased plasma inflammatory biomarkers, most consistently interleukin (IL)-1b, IL-6, tumor necrosis factor (TNF)-a, and C-reactive protein. 9, 10 Blockade of the production of these cytokines is associated with reduced depressive symptoms.
11e14 Studies in the perinatal period have suggested that postpartum depression is associated with increased plasma inflammatory biomarkers, most consistently IL-1b, soluble IL-1 receptor antagonist, and IL- 6. 15e18 While peripheral cytokines are able to cross the blood-brain barrier 1 , equilibrium between cerebrospinal fluid (CSF) and plasma is not established and peripheral blood markers may not reflect the intracerebral environment milieu. 19 Although cytokines are large molecules, a variety of mechanisms facilitate transport between plasma and CSF. These include the following: (1) leaky regions of the blood-brain barrier, (2) active transport via various facilitative molecules, (3) activation of cells surrounding the cerebral vasculature, and (4) binding of cytokine receptors on peripheral afferent nerve fibers. 1 When inflammatory cytokines are present in the CSF, they can cause damage to existing nerve cells as well as inhibition of neural cell growth in the hippocampus, amygdala, prefrontal cortex, anterior cingulate, and basal ganglia, which leads to symptoms of depression. 20 There is conflicting reported evidence between depressive symptomatology and CSF inflammatory biomarkers (Table 1) . Heterogeneity in research methodology, including indications and circumstances for undergoing a lumbar puncture, may explain some of these reported differences.
Pregnancy further complicates the inflammatory assessment because normal pregnancy represents a state of immunologic changes. As pregnancy progresses, increases in peripheral phagocytic (monocytes and granulocytes) and dendritic cells have been observed that are partially offset by decreases in CD4, CD8, B, and NK cells. Original Research ajog.org Correspondingly, plasma cytokines and chemokines involved in phagocytic recruitment, such as TNFa, increase, whereas plasma inflammatory molecules, such as vascular endothelial growth factor and interferon (IFN)-g decrease throughout gestation. 22 Despite these changes, perinatal depression has been shown to be associated with increased plasma inflammatory cytokines, similar to major depressive disorder outside pregnancy. 15e18 The association between depressive symptomatology and CSF inflammatory cytokines has not been well established in pregnant patients. A positive correlation between CSF IL-6 and TNFa and scores on the Edinburgh Postnatal Depression Scale has been reported in parturients; however, the authors did not account for the potential underlying impact of labor itself or establish clinical diagnoses of major depressive disorder. 23 Perinatal depression, or depression that begins either during pregnancy or within 12 months postpartum, is one of the most common complications of pregnancy affecting approximately 1 in 7 women. 24, 25 However, the majority of women with depression are neither identified nor treated. 26, 27 This disparity between clinical need and care provision is not due to a lack of access to the health care system in general because contact with health care professionals is typically increased in the perinatal period. The unmet need reflects barriers to mental health care. 27 Furthermore, current treatments are not often fully effective, and only a minority of women achieve a therapeutic response. 26, 27 Defining the mechanistic underpinnings of perinatal depression, including the role of inflammation, is critical to developing more effective interventions. To address this gap in knowledge, we examined the association between both plasma and CSF inflammatory cytokines and perinatal depression. We hypothesized that women with perinatal depression would exhibit higher concentrations of inflammatory cytokines in the plasma and CSF compared with euthymic women.
Materials and Methods Overview
This prospective observational study aimed to compare inflammatory cytokines in simultaneous plasma and CSF samples from women at term with and without an antenatal major depressive episode. A second aim was to determine whether inflammatory cytokines in the plasma or CSF correlate with later postpartum depressive symptomatology. The third aim was to assess the correlation between CSF and maternal plasma inflammatory cytokines. The
Northwestern University Institutional Review Board approved this study, and all women provided written informed consent.
Subjects
Women with singleton, term gestations who were undergoing a scheduled cesarean delivery were eligible for participation. Women in labor (either clinically diagnosed, self-reported to have regular painful contractions, or endorsing leakage of fluid) were excluded because of the potential of the parturition process to alter markers of inflammation obtained at the time of epidural or spinal placement. Similarly, women with diabetes or preeclampsia were excluded because of their potential to confound observed associations, given their relationship with depression 28, 29 and their inflammatory underpinnings. 30 Women also were excluded if they were younger than 18 years old, had diagnosed anomalies in their fetuses, were living with HIV, or were taking antiinflammatory medications (eg, steroids, nonsteroidal antiinflammatory drugs) within 2 weeks of delivery. For this analysis, women treated with antidepressants also were excluded because of the antiinflammatory effects of these medications.
31e35

Measures and procedures
Women who presented for a scheduled cesarean delivery were approached upon admission for surgery and, after consent was obtained, screened for depression using the Inventory of Depressive Symptomatology-Self-Report (IDS-SR 30 ). The IDS-SR 30 is a depression screen with excellent psychometric properties, 36 with a reported sensitivity of 78% and specificity of 76% for prenatal depression. 37 The IDS-SR 30 Original Research OBSTETRICS ajog.org was enrolled for every 2 screen-positive women (IDS-SR!18) who were identified. An IDS-SR score above 11 signifies mild depression, whereas a score above 23 signifies moderate depression.
The choice of 18 as a cutoff was made to enrich the sample with women who had more significant symptomatology to ensure an adequate sample of women with clinical major depressive disorder for analysis. A member of the research team, trained and supervised by a perinatal psychologist, administered the Mini-International Neuropsychiatric Interview (MINI, version 5.0.0) in all enrolled women as the gold standard used to confirm the clinical diagnosis of an active antenatal major depressive episode as well as to identify any other Diagnostic and Statistical Manual of Mental Disorders, fourth edition, psychiatric diagnoses.
While establishing intravenous access, 15 mL of maternal blood was drawn; this sample was centrifuged at e4 C to obtain plasma, which was immediately stored at e80 C. At the time of spinal analgesia administration, 2 mL of CSF was aspirated prior to anesthetic injection and immediately stored at e80 C. Both plasma and CSF samples were assayed in duplicate using flow cytometry and a multiplex bead-based assay panel for 13 inflammatory cytokines/ chemokines including IL-1b, IFN-a, IFN-g, TNF-a, monocyte chemotactic protein (MCP)-1, IL-6, IL-8, IL-10, IL12p70, IL-17A, IL-18, IL-23, and IL-33 (LEGENDplex; BioLegend, San Diego, CA).
This panel was chosen because it includes cytokines previously associated with major depressive disorder or perinatal depression in the existing literature. 9, 10, 23 Characteristics of the assay, including sensitivity and cross-reactivity are available online. 38 The minimum detectable concentration in serum has been reported to be between 0.6 and 1.9 pg/mL for each of the examined cytokines. Each sample was tested in triplicate and each sample was run twice in independent assays. The assay used monoclonal antibodies that have been well characterized and have no known cross-reactivity.
On postpartum day 1, self-reported surveys were administered to collect sociodemographic characteristics. In addition, members of the research team abstracted the medical and obstetric history from the electronic medical records with quality control via spot checks performed by another investigator (E.S.M.). An assessment of perceived stress, measured using Cohen's Perceived Stress Scale (PSS), was obtained, 39 given the established relationship between stress and inflammatory cytokines. 40, 41 Women were contacted via electronic mail between 4 and 8 weeks postpartum, at which time they were asked to complete a followup IDS-SR 30 .
Statistical analyses
Women were stratified by the diagnosis of a current antenatal major depressive episode (MDE). Sociodemographic and clinical characteristics, as well as PSS scores, were compared across these 2 groups using c 2 , Fisher exact, or MannWhitney U tests as appropriate. Plasma and CSF cytokine concentrations were compared between women with and ajog.org
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without an MDE using Mann-Whitney U tests. Plasma and CSF cytokines that differed between women with and without an MDE at the 20% level of significance (ie, P < .20) were entered into multivariable logistic regression models for the outcome of MDE. Potential confounders were identified using the change in estimate criteria of 10%, in which variables that altered the unadjusted exposureoutcome association by 10% or more were included in multivariable models to establish whether each assayed plasma or CSF cytokine was independently associated with the presence of an MDE. Analyses further involved Spearman's sample correlation coefficients of the entire cohort to evaluate a potential relationship between cytokine concentrations and antenatal depressive symptomatology (IDS-SR score). A subscale of the IDS-SR allowed for assessment of the presence of symptoms ascribed to the inflammatory subtype of depression (atypical depression), 13 and Spearman's correlations were used to estimate the association between cytokine concentrations and atypical depressive symptoms. Spearman's correlations were used to estimate the associations between the cytokine concentrations and the postpartum IDS-SR score. Finally, Spearman's correlations between CSF and maternal plasma inflammatory cytokines were also estimated. Analyses were performed using Stata version 14.0 (StataCorp, College Station, TX). Tests were all 2 tailed and, unless otherwise specified, assumed a 5% level of statistical significance. We did not adjust P values to account for multiple hypothesis tests. (Figure) . Of the 76 women who endorsed at least moderate depressive symptomatology on the IDS-SR 30 (IDS-SR 30 !18), 15 (20%) had an MDE based on the MINI evaluation. Of these 15 women, 14 (93%) had a comorbid anxiety disorder, and 6 (40%) had a history suggestive of possible bipolar disorder based on their MINI evaluation.
Results
Cohort characteristics
Of the 61 screen-positive women who did not have an MDE, 11 (18%) had an active anxiety disorder and 4 (5%) had a history of possible bipolar disorder based on their MINI evaluation. The remainder of women had subclinical depressive symptoms, given the absence of diagnostic criteria for a major depressive episode.
Baseline characteristics of the cohort stratified by the presence of an MDE determined by the MINI are shown in Table 2 . Compared with women not experiencing an MDE, women with an MDE tended to be younger, have a lower household income, have a higher body mass index at delivery, have a lower level of education, and were more likely to be nonHispanic black. Women with an MDE also had higher levels of perceived stress.
Antenatal depression and cytokines
The standard curve for each cytokine was 2e10,000 pg/mL. Prior to testing any clinical samples, recombinant IL-6, IL-8, and IFN gamma were purchased and titered into 3 independent plasma and CSF samples for assay. The calculated curves ([plasma or CSF þ cytokine] e [plasma or CSF alone]) for all 3 cytokines were as expected, indicating that the assay performed as described in Empiric distributions of plasma and CSF cytokines were highly skewed (assessed using the Shapiro-Wilk normality test) despite attempted transformations (including cubic, square, square root, log, 1/square root, inverse, 1/square, and 1/cubic transformations); therefore, analyses involved nonparametric methods. IL-1b and IL-33 were below the limits of detection in the plasma. There were no significant differences in plasma cytokines between women with and without an MDE (Table 3) . Aside from IL-6, point estimates for all measured CSF inflammatory cytokines were higher in women experiencing an MDE compared with those without an MDE, although none of these differences reached statistical significance (Table 3) . A post hoc power calculation, using an alpha of 0.05, demonstrated that we had 80% power to identify a 1.8-, 1.3-, and 1.4-fold change in CSF IL-1b, IL-6, and TNF-a, respectively, associated with a major depressive episode.
Because CSF IL-1b, IL-18, IL-23, and IL-33 were associated with an MDE at a significance level less than .2, they were included in the planned multivariable analyses. IL-1b, IL-23, and IL-33 all were significantly associated with an MDE after controlling for potential confounders (Table 4) .
Antenatal depressive symptomatology and cytokines
There were no significant correlations between antenatal IDS-SR scores and any plasma or CSF cytokine (Table 5 ).
Atypical depression
There was a weak correlation between atypical depression and plasma IFN-g but no significant correlation between any of the other plasma or CSF cytokines and the IDS-SR 30 atypical depression scores (Table 6 ). These findings were unchanged when women with other psychiatric comorbidities were excluded from analysis (data not shown).
Postpartum depressive symptomatology
Of the 117 women who met inclusion criteria, 90 (77%) completed a postpartum IDS-SR 30 : 46 (51%) with no, 34 (38%) with mild, 9 (10%) with moderate, and 1 (1%) with severe depressive symptoms. There was an observed weak correlation between plasma IL-10 and postpartum depressive symptomatology, but no other significant correlations between postpartum IDS-SR scores and the measured plasma or CSF inflammatory cytokines (Table 6 ).
Correlations between plasma and CSF cytokines
Plasma IL-6, IL-8, IFN-g, and MCP-1 were not significantly correlated with their corresponding CSF cytokines. While (Table 7) .
Comment
Findings and proposed pathophysiology
In term pregnant women, CSF concentrations of IL-1b, IL-23, and IL-33 are increased in the setting of an active major depressive episode. IL-1b and IL-33 are both in the IL-1 family of cytokines and may be mechanistically linked with antenatal depression via associated alterations in tryptophan metabolism. 42 Tryptophan is the precursor to serotonin, a monoamine whose production is critical to mood stability. Th1-cytokines, such as the IL-1 family of cytokines, induce expression of indolamine-2,3-dioxygenase, which degrades tryptophan into its catabolites (ie, kynurenine and quinolinic acid). Not only does the breakdown of tryptophan yield a state of relative serotonin depletion, but these catabolites have also been shown to independently induce depressive and anxiety symptoms.
IL-23 has received less study in the pathogenesis of depression. IL-23 is a proinflammatory cytokine involved in the differentiation of Th17 lymphocytes. 43 In this role, IL-23 has recently been recognized as essential in the development of autoimmunity, and trials of antibodies to IL-23 for the treatment of psoriasis, rheumatoid arthritis, and Crohn's disease are underway. 44 Based on our results along with the promising preliminary findings in other disease states with a dysregulated inflammatory system, further investigation of the role of Th17 lymphocytes and the IL-23 immune axis in the pathophysiology of depression is warranted.
Comparison to existing literature
In contrast to the CSF findings, plasma concentrations of inflammatory cytokines were not associated with depressive symptomatology, atypical depressive symptomatology, or an active major depressive episode. These findings differ from previous reports.
15e18 One reason for this discrepancy might be that this investigation excluded women who have experienced antenatal inflammatory conditions such as preterm labor, preeclampsia, or diabetes. Perhaps by systematically excluding women with these complications, we selected a subgroup of antenatal depression that did not have an inflammatory phenotype. To the best of our knowledge, there is only 1 prior manuscript assessing CSF cytokines and postpartum depressive symptomatology. Boufidou et al 23 demonstrated a positive association between the two CSF cytokines examined, IL-6 and TNF-a, and depressive mood symptoms in the first 4 days postpartum. While we did not identify significant correlations between these cytokines and postpartum depressive symptomatology, as described in the previous text, our restrictive inclusion criteria may have masked an association that may be present in a more generalized population.
Strengths and limitations
The results of our study are strengthened by the use of the MINI to achieve a Each of these characteristics of the study sample may limit the generalizability of the findings when applied to the broader obstetric population. In addition, we do not have data on the serum/CSF albumin ratio, which has been postulated to impact CSF concentrations of cytokines 45 and may be influenced by inflammatory mechanisms. 46 Another limitation is that, given the relatively small sample size of women with an active MDE, bivariable analyses between cytokines and perinatal depression were not significant and our multivariable models may be oversaturated. While this should raise some caution when interpreting the results, the consistent association between IL-1b, IL-23, and IL-33 concentrations and MDE in both bivariable and multivariable analyses supports the veracity of this relationship.
Similarly, because of the relatively small sample size, convergence could not be achieved when attempting to fit the data into a log-linear model, and thus, a logistic regression with its associated odds ratio is reported. Consequently, the magnitude of the observed associations in the multivariable analyses may be slightly lower than those reflected in the reported odds ratios.
Finally, given their antiinflammatory effects, 31e35 this study excluded women with perinatal depression taking antidepressant medications, and the results may not apply to them. However, because the majority of women with perinatal depression in the United States do not receive treatment, 27, 47 we believe that this exclusion results in applicability to many women with major depressive disorder and is more reflective of the 
Depressive symptomatology
We were unable to identify a doseresponse relationship between antenatal depressive symptomatology and CSF inflammatory cytokines, which raises caution in interpreting the observed associations. One explanation could be a threshold effect of inflammation that yields overt depression (defined by the MINI) and that subclinical depressive symptoms (ie, women with a positive IDS-SR 30 but a negative screen for a major depressive episode on the MINI) represent a separate pathophysiology. Alternatively, as evidenced by the discordance between the IDS-SR screen results and the diagnostic findings on the MINI, the heterogeneity of diagnoses uncovered by a positive IDS-SR (eg, anxiety, bipolar disorder) biases correlations between overt depressive symptomatology and inflammatory cytokines toward the null. In addition, there was not a strong correlation between postpartum depressive symptomatology and any of the measured plasma or CSF inflammatory cytokines. This suggests that any observed cytokine alterations are a transient finding and not a harbinger for future depressive symptoms.
Implications of the findings
Notably, we identified a lack of strong correlation between plasma and CSF inflammatory cytokines. The discrepancy between plasma and CSF cytokines emphasizes the critical need for paired CSF and plasma for biomarker development research and novel therapeutic development in the field of perinatal depression. Specific focus should be paid to the pathophysiologic mechanisms that may link CSF IL-1b, IL-23, and IL-33 concentrations with development of a MDE.
Conclusion
In conclusion, CSF concentrations of the inflammatory cytokines IL-1b, IL-23, and IL-33 are independently associated with an MDE in pregnant women at term. These findings support a neuroinflammatory mechanism for perinatal 
